| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -59.9% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | 1.6 | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 2.0 | n/a |
| Pr/Book | 0.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 22.2% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-20 | n/a | (1.24) | (4.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.45 | (1.95) | (0.03)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 0.99 | (0.87) | (1.15)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 0.92 | (0.44) | (0.86)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 1.12 | (0.75) | 0.88p | 2.7 | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Interim results | 29-Sep-2025 | 07:00 | RNS |
| Corporate Update | 26-Sep-2025 | 07:00 | RNS |
| Issue of Shares to Russell Lamming | 14-Aug-2025 | 16:40 | RNS |
| Actavis buys speciality drugmaker Forest Labs fo... | 19-Feb-2014 | Guardian |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.40p |
| Change Today | -0.050p |
| % Change | -3.45 % |
| 52 Week High | 2.40 |
| 52 Week Low | 1.15 |
| Volume | 82,083 |
| Shares Issued | 156.87m |
| Market Cap | £2.20m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:52 | 18,508 @ 1.33p |
| 09:55 | 53,375 @ 1.33p |
| 09:39 | 10,000 @ 1.33p |
| 09:28 | 200 @ 1.54p |
You are here: research